Iovance Biotherapeutics Q1 2026 Earnings EPS Misses Estimates but Stock Rises on Operational Momentum FMC Q1 2026 Earnings NarrowerThanExpected Loss Boosts Investor Sentiment FFIN Q1 2026 Earnings EPS Beats Estimates by 38 TRDA Q1 2026 Earnings SmallerThanExpected Loss Offers Cautious Optimism Amid PreRevenue Stage MLKN Q1 2026 Earnings EPS Misses Estimates Stock Still Closes Higher